• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞在非酒精性脂肪性肝病纤维化进展中的作用

The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease.

作者信息

Almeda-Valdes Paloma, Aguilar Olivos Nancy E, Barranco-Fragoso Beatriz, Uribe Misael, Méndez-Sánchez Nahum

机构信息

Endocrinology and Metabolism Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14080 Mexico, DF, Mexico.

Liver Research Unit, Medica Sur Clinic & Foundation, 14050 Mexico, DF, Mexico.

出版信息

Biomed Res Int. 2015;2015:768071. doi: 10.1155/2015/768071. Epub 2015 Aug 3.

DOI:10.1155/2015/768071
PMID:26339640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4538585/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver disease. NAFLD encompasses a wide range of pathologies, from simple steatosis to steatosis with inflammation to fibrosis. The pathogenesis of NAFLD progression has not been completely elucidated, and different liver cells could be implicated. This review focuses on the current evidence of the role of liver dendritic cells (DCs) in the progression from NAFLD to fibrosis. Liver DCs are a heterogeneous population of hepatic antigen-presenting cells; their main function is to induce T-cell mediated immunity by antigen processing and presentation to T cells. During the steady state liver DCs are immature and tolerogenic. However, in an environment of chronic inflammation, DCs are transformed to potent inducers of immune responses. There is evidence about the role of DC in liver fibrosis, but it is not clearly understood. Interestingly, there might be a link between lipid metabolism and DC function, suggesting that immunogenic DCs are associated with liver lipid storage, representing a possible pathophysiological mechanism in NAFLD development. A better understanding of the interaction between inflammatory pathways and the different cell types and the effect on the progression of NAFLD is of great relevance.

摘要

非酒精性脂肪性肝病(NAFLD)是慢性肝病最常见的病因。NAFLD涵盖了广泛的病理情况,从单纯性脂肪变性到伴有炎症的脂肪变性再到纤维化。NAFLD进展的发病机制尚未完全阐明,不同的肝细胞可能与之相关。本综述聚焦于肝脏树突状细胞(DCs)在NAFLD向纤维化进展过程中作用的当前证据。肝脏DCs是肝脏抗原呈递细胞的异质性群体;它们的主要功能是通过抗原加工和呈递给T细胞来诱导T细胞介导的免疫。在稳态时,肝脏DCs不成熟且具有耐受性。然而,在慢性炎症环境中,DCs会转变为免疫反应的强效诱导剂。有关于DC在肝纤维化中作用的证据,但尚未完全明确。有趣的是,脂质代谢与DC功能之间可能存在联系,这表明具有免疫原性的DCs与肝脏脂质储存相关,代表了NAFLD发展中一种可能的病理生理机制。更好地理解炎症途径与不同细胞类型之间的相互作用以及对NAFLD进展的影响具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/4538585/a423a1bc3e7f/BMRI2015-768071.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/4538585/99092a53e18e/BMRI2015-768071.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/4538585/deb77afb9636/BMRI2015-768071.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/4538585/a423a1bc3e7f/BMRI2015-768071.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/4538585/99092a53e18e/BMRI2015-768071.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/4538585/deb77afb9636/BMRI2015-768071.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/4538585/a423a1bc3e7f/BMRI2015-768071.003.jpg

相似文献

1
The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease.树突状细胞在非酒精性脂肪性肝病纤维化进展中的作用
Biomed Res Int. 2015;2015:768071. doi: 10.1155/2015/768071. Epub 2015 Aug 3.
2
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.非酒精性脂肪性肝病:从非酒精性脂肪性肝病到非酒精性脂肪性肝炎的进展中的基本发病机制。
Transplantation. 2019 Jan;103(1):e1-e13. doi: 10.1097/TP.0000000000002480.
3
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的病理生理学及机制
Annu Rev Physiol. 2016;78:181-205. doi: 10.1146/annurev-physiol-021115-105331. Epub 2015 Nov 30.
4
Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis.肠道来源的细菌产物可刺激非酒精性脂肪性肝炎的发生。
Pharmacol Res. 2019 Mar;141:418-428. doi: 10.1016/j.phrs.2019.01.026. Epub 2019 Jan 15.
5
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.非酒精性脂肪性肝炎发病机制中的脂质氧化产物。
Free Radic Biol Med. 2017 Oct;111:173-185. doi: 10.1016/j.freeradbiomed.2017.01.023. Epub 2017 Jan 18.
6
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.在小鼠的高脂肪-高胆固醇-高糖饮食模型中,非酒精性脂肪变性进展为脂肪性肝炎和肝纤维化与促进炎症和肝肿瘤的危险信号的累积平行。
J Transl Med. 2015 Jun 16;13:193. doi: 10.1186/s12967-015-0552-7.
7
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?代谢综合征与非酒精性脂肪性肝病:胰岛素抵抗是其中的关联因素吗?
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:55-65. doi: 10.1016/j.mce.2015.02.018. Epub 2015 Feb 24.
8
Molecular pathways of nonalcoholic fatty liver disease development and progression.非酒精性脂肪性肝病发生和进展的分子途径。
Cell Mol Life Sci. 2019 Jan;76(1):99-128. doi: 10.1007/s00018-018-2947-0. Epub 2018 Oct 20.
9
Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.蛋白激酶STK25调节肝脏脂质分配以及肝脂肪变性和非酒精性脂肪性肝炎的进展。
FASEB J. 2015 Apr;29(4):1564-76. doi: 10.1096/fj.14-264937. Epub 2015 Jan 21.
10
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.脂肪变性诱导的CCL5在非酒精性脂肪性肝病进展中促成早期肝纤维化。
Transl Res. 2017 Feb;180:103-117.e4. doi: 10.1016/j.trsl.2016.08.006. Epub 2016 Aug 31.

引用本文的文献

1
Neutrophils in MASLD and MASH.非酒精性脂肪性肝炎相关肝脂肪变性(MASLD)和非酒精性脂肪性肝炎(MASH)中的中性粒细胞
BMB Rep. 2025 Mar;58(3):116-123. doi: 10.5483/BMBRep.2024-0058.
2
Six-gene prognostic signature for non-alcoholic fatty liver disease susceptibility using machine learning.基于机器学习的非酒精性脂肪性肝病易感性六基因预后标志。
Medicine (Baltimore). 2024 May 10;103(19):e38076. doi: 10.1097/MD.0000000000038076.
3
Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study.胆囊切除术后患者 MAFLD 相关的分子机制:一项队列研究。

本文引用的文献

1
Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies.检测不同病因肝硬化中肝肌成纤维细胞的策略
Curr Pathobiol Rep. 2014;2(4):209-215. doi: 10.1007/s40139-014-0057-8.
2
Human dendritic cell functional specialization in steady-state and inflammation.稳态和炎症状态下人类树突状细胞的功能特化
Front Immunol. 2014 Apr 1;5:131. doi: 10.3389/fimmu.2014.00131. eCollection 2014.
3
The prevalence of nonalcoholic fatty liver disease in the Americas.美洲非酒精性脂肪性肝病的患病率。
Genes (Basel). 2023 Oct 13;14(10):1935. doi: 10.3390/genes14101935.
4
Characteristic gene expression in the liver monocyte-macrophage-DC system is associated with the progression of fibrosis in NASH.特征性基因表达在肝脏单核细胞-巨噬细胞-DC 系统中与 NASH 纤维化的进展相关。
Front Immunol. 2023 Feb 24;14:1098056. doi: 10.3389/fimmu.2023.1098056. eCollection 2023.
5
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease.免疫与代谢在非酒精性脂肪性肝病共病发病机制中的关联。
World J Gastroenterol. 2023 Jan 28;29(4):597-615. doi: 10.3748/wjg.v29.i4.597.
6
Pathogenesis from Inflammation to Cancer in NASH-Derived HCC.非酒精性脂肪性肝炎相关肝细胞癌中从炎症到癌症的发病机制
J Hepatocell Carcinoma. 2022 Aug 26;9:855-867. doi: 10.2147/JHC.S377768. eCollection 2022.
7
Enrichment Methods for Murine Liver Non-Parenchymal Cells Differentially Affect Their Immunophenotype and Responsiveness towards Stimulation.富集方法对小鼠肝非实质细胞的免疫表型及其对刺激的反应性有不同影响。
Int J Mol Sci. 2022 Jun 11;23(12):6543. doi: 10.3390/ijms23126543.
8
Dendritic cells trigger imbalance of Th1/Th2 cells in silica dust exposure rat model MHC-II, CD80, CD86 and IL-12.在二氧化硅粉尘暴露大鼠模型中,树突状细胞引发Th1/Th2细胞失衡、主要组织相容性复合体II类分子、CD80、CD86和白细胞介素-12。
RSC Adv. 2018 Jul 20;8(46):26108-26115. doi: 10.1039/c8ra03970d. eCollection 2018 Jul 19.
9
Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的免疫相关发病机制和治疗策略。
Arch Pharm Res. 2022 Apr;45(4):229-244. doi: 10.1007/s12272-022-01379-1. Epub 2022 Apr 7.
10
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.非酒精性脂肪性肝病中的炎症与纤维化:肝脏免疫系统的作用
Front Med (Lausanne). 2021 Dec 9;8:781567. doi: 10.3389/fmed.2021.781567. eCollection 2021.
Ann Hepatol. 2014 Mar-Apr;13(2):166-78.
4
Reply to: "Dendritic cell subset composition in the human liver is more complex than it seems".回复:“人类肝脏中树突状细胞亚群的组成比看起来更复杂”。
J Hepatol. 2014 May;60(5):1098-9. doi: 10.1016/j.jhep.2013.12.029. Epub 2014 Jan 10.
5
Dendritic cells in liver injury and fibrosis: shortcomings and promises.肝脏损伤和纤维化中的树突状细胞:缺陷与前景。
J Hepatol. 2013 Nov;59(5):1124-6. doi: 10.1016/j.jhep.2013.05.033. Epub 2013 May 29.
6
NKT-cell subsets: promoters and protectors in inflammatory liver disease.自然杀伤 T 细胞亚群:炎症性肝病的启动子和保护者。
J Hepatol. 2013 Sep;59(3):618-20. doi: 10.1016/j.jhep.2013.02.032. Epub 2013 May 10.
7
Dendritic cells in NASH: friend or foe?非酒精性脂肪性肝炎中的树突状细胞:朋友还是敌人?
Ann Hepatol. 2013 May-Jun;12(3):508-9.
8
Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.树突状细胞限制了非酒精性脂肪性肝炎小鼠的纤维炎症损伤。
Hepatology. 2013 Aug;58(2):589-602. doi: 10.1002/hep.26267. Epub 2013 Jun 24.
9
Dendritic cells and liver fibrosis.树突状细胞与肝纤维化
Biochim Biophys Acta. 2013 Jul;1832(7):998-1004. doi: 10.1016/j.bbadis.2013.01.005. Epub 2013 Jan 9.
10
Chemokines in tissue fibrosis.组织纤维化中的趋化因子。
Biochim Biophys Acta. 2013 Jul;1832(7):1041-8. doi: 10.1016/j.bbadis.2012.11.004. Epub 2012 Nov 15.